Trial Profile
An observational study evaluating the safety and tolerability of regadenoson, in patients referred for single photon emission computed tomography myocardial perfusion imaging
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Apr 2017
Price :
$35
*
At a glance
- Drugs Regadenoson (Primary)
- Indications Coronary disorders
- Focus Adverse reactions
- 17 Apr 2017 New trial record